<DOC>
	<DOCNO>NCT02181322</DOCNO>
	<brief_summary>Study assess effect food pharmacokinetics meloxicam single p.o . administration 22.5 mg meloxicam oral suspension investigate dose-proportionality dosage range 7.5 mg 22.5 mg</brief_summary>
	<brief_title>Study Assess Effect Food Pharmacokinetics Meloxicam After Single Administration Investigate Dose-proportionality Over Dosage Range</brief_title>
	<detailed_description />
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Healthy male female subject determine result screen Age range 21 50 year BrocaIndex + 20 % In accordance Good Clinical Practice ( GCP ) local legislation volunteer give write informed consent prior admission study Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Disease central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month less ten halflives respective drug enrolment study Use drug might influence result trial ( &lt; = one week prior administration trial ) Participation another trial investigational drug ( &lt; = two month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( &gt; = 100 mL within four week prior administration trial Excessive physical activity ( within last week study ) Anl laboratory value outside reference range clinical relevance History haemorrhagic diatheses History gastrointestinal ulcer , perforation bleed History bronchial asthma For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g sterilisation , intrauterine pessary , oral contraceptive Inability maintain adequate contraception whole study period Lactating</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>